ACUTE LYMPHOBLASTIC LEUKAEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: experimental drug CC312 enters human testing
Disease control Recruiting nowThis early-stage study tests an experimental drug called CC312 in about 44 adults with certain blood cancers (like lymphoma or leukemia) that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. Research…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New pill targets tough blood cancers in early trial
Disease control Recruiting nowThis study tests a new oral drug, AZD3632, in people with advanced blood cancers like leukemia and myelodysplastic syndromes that have certain genetic changes. The main goals are to check the drug's safety and find the right dose. About 84 participants will take the drug alone or…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 06, 2026 16:03 UTC